CO5580781A2 - BENZOXAZINE AND BENZOTIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
BENZOXAZINE AND BENZOTIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- CO5580781A2 CO5580781A2 CO04035089A CO04035089A CO5580781A2 CO 5580781 A2 CO5580781 A2 CO 5580781A2 CO 04035089 A CO04035089 A CO 04035089A CO 04035089 A CO04035089 A CO 04035089A CO 5580781 A2 CO5580781 A2 CO 5580781A2
- Authority
- CO
- Colombia
- Prior art keywords
- derivatives
- substituted
- thio
- unsubstituted
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
1.- Nuevos compuestos caracterizados porque son de la fórmula (I) sus derivados, sus análogos, sus formas tautoméricas, sus estereoisómeros, sus polimorfos, sus sales farmacéuticamente aceptables, sus solvatos farmacéuticamente aceptables, donde R1, R2 y R3, R4 cuando se unen al átomo de carbono, pueden ser los mismos o diferentes y representan hidrógeno, halógeno, hidroxi, nitro, ciano, formilo o grupos substituidos o insubstituidos seleccionados de alquilo, cicloalquilo, alcoxi, cicloalcoxi, arilo, ariloxi, aralquilo, aralcoxi, heterociclilo, heteroarilo, heteroaralquilo, heteroariloxi, heteroaralcoxi, acilo, aciloxi, hidroxialquilo, amino, acilamino, monoalquilamino, dialquilamino, arilamino, aralquilamino, alcoxicarbonilo, ariloxicarbonilo, aralcoxicarbonilo, alcoxialquilo, ariloxialquilo, aralcoxialquilo, alquiltio, tioalquilo, alcoxicarbonilamino, ariloxicarbonilamino, aralcoxicarbonilamino, ácido carboxílico o sus derivados, o ácido sulfónico o sus derivados; uno o ambos de R3 y R4 pueden representar un grupo oxo o tioxo cuando están unidos a un átomo de carbono; R3 y R4 cuando están unidos a un átomo de nitrógeno representan hidrógeno, hidroxi, formilo o grupos substituidos o insubstituidos seleccionados de grupos alquilo, cicloalquilo, alcoxi, cicloalcoxi, arilo, aralquilo, heterociclilo, heteroarilo, heteroaralquilo, acilo, aciloxi, hidroxialquilo, amino, acilamino, monoalquilamino, dialquilamino, arilamino, aralquilamino, aminoalquilo, ariloxi, aralcoxi, heteroariloxi, heteroaralcoxi, alcoxicarbonilo, ariloxicarbonilo, aralcoxicarbonilo, alcoxialquilo, ariloxialquilo, aralcoxialquilo, alquiltio, tioalquilo, derivados de ácido carboxílico, o derivados de ácido sulfónico; X representa un heteroátomo seleccionado de oxígeno o azufre; W representa NR12, -C(=O)-(CR10R11)o-NR12, -O-arilo-(CR10R11)o-NR12, en donde R12 representa hidrógeno o un grupo substituido o insubstituido seleccionado de grupos alquilo, arilo o aralquilo; o es un entero que varía de 0-6; R10 y R11 pueden ser los mismos o diferentes y representan hidrógeno o un grupo substituido o insubstituido seleccionado del grupo alquilo, alcoxi, arilo o aralquilo; Ar representa un grupo aromático o heterocíclico substituido o insubstituido divalente único o fusionado seleccionado del grupo fenileno, naftileno, pirrolilo, piridilo, quinolilo, benzofurilo, dihidrobenzofurilo, benzopiranilo, dihidrobenzopiranilo, indolilo, indolinilo, ...1.- New compounds characterized in that they are of the formula (I) their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, where R1, R2 and R3, R4 when bind to the carbon atom, may be the same or different and represent hydrogen, halogen, hydroxy, nitro, cyano, formyl or substituted or unsubstituted groups selected from alkyl, cycloalkyl, alkoxy, cycloalkoxy, aryl, aryloxy, aralkyl, aralkoxy, heterocyclyl, heteroaryl, heteroaralkyl, heteroaryloxy, heteroaralkoxy, acyl, acyloxy, hydroxyalkyl, amino, acylamino, monoalkylamino, dialkylamino, arylamino, aralkylamino, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, alkoxyalkyl, aryloxyalkyl, aralkoxyalkyl, alkylthio, thioalkyl, alkoxycarbonylamino, aryloxycarbonylamino, aralkoxycarbonylamino, carboxylic acid or its derivatives, or sulfonic acid or its derivatives; one or both of R3 and R4 may represent an oxo or thioxo group when attached to a carbon atom; R3 and R4 when attached to a nitrogen atom represent hydrogen, hydroxy, formyl or substituted or unsubstituted groups selected from alkyl, cycloalkyl, alkoxy, cycloalkoxy, aryl, aralkyl, heterocyclyl, heteroaryl, heteroaralkyl, acyl, acyloxy, hydroxyalkyl, amino groups , acylamino, monoalkylamino, dialkylamino, arylamino, aralkylamino, aminoalkyl, aryloxy, aralkoxy, heteroaryloxy, heteroaralkoxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, alkoxyalkyl, aryloxyalkyl, aralkoxyalkyl, alkylthio, carboxylic acid, thio derivatives, thio derivatives, thio derivatives, thio derivatives, thio derivatives, thio derivatives, thio derivatives, thio, derivatives X represents a heteroatom selected from oxygen or sulfur; W represents NR12, -C (= O) - (CR10R11) or-NR12, -O-aryl- (CR10R11) or-NR12, wherein R12 represents hydrogen or a substituted or unsubstituted group selected from alkyl, aryl or aralkyl groups; or is an integer that varies from 0-6; R10 and R11 may be the same or different and represent hydrogen or a substituted or unsubstituted group selected from the alkyl, alkoxy, aryl or aralkyl group; Ar represents a single or fused substituted or unsubstituted substituted or unsubstituted aromatic or heterocyclic group selected from the phenylene, naphthylene, pyrrolyl, pyridyl, quinolyl, benzofuryl, dihydrobenzofuryl, benzopyranyl, dihydrobenzopyranyl, indolyl, indolinyl, ... group.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN848MA2001 | 2001-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5580781A2 true CO5580781A2 (en) | 2005-11-30 |
Family
ID=35824329
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04035089A CO5580781A2 (en) | 2001-10-16 | 2004-04-16 | BENZOXAZINE AND BENZOTIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
CO04035096A CO5580819A2 (en) | 2001-10-16 | 2004-04-16 | NEW PROPIONIC DERIVATIVES B-FENIL-A-OXISUBSTITUIDOS: PROCESS FOR ITS PREPARATION AND ITS USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COPMPUESTOS |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04035096A CO5580819A2 (en) | 2001-10-16 | 2004-04-16 | NEW PROPIONIC DERIVATIVES B-FENIL-A-OXISUBSTITUIDOS: PROCESS FOR ITS PREPARATION AND ITS USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COPMPUESTOS |
Country Status (9)
Country | Link |
---|---|
KR (2) | KR20040052242A (en) |
CN (1) | CN1982299A (en) |
AU (1) | AU2002341289B2 (en) |
CO (2) | CO5580781A2 (en) |
MX (2) | MXPA04003628A (en) |
NZ (1) | NZ532284A (en) |
RS (2) | RS32404A (en) |
RU (2) | RU2004111792A (en) |
UA (1) | UA78522C2 (en) |
-
2002
- 2002-10-15 UA UA20040402821A patent/UA78522C2/en unknown
- 2002-10-15 MX MXPA04003628A patent/MXPA04003628A/en active IP Right Grant
- 2002-10-15 RU RU2004111792/04A patent/RU2004111792A/en not_active Application Discontinuation
- 2002-10-15 RU RU2004111786/04A patent/RU2004111786A/en not_active Application Discontinuation
- 2002-10-15 KR KR10-2004-7005691A patent/KR20040052242A/en not_active Application Discontinuation
- 2002-10-15 CN CNA2006101562285A patent/CN1982299A/en active Pending
- 2002-10-15 KR KR10-2004-7005690A patent/KR20040048960A/en not_active Application Discontinuation
- 2002-10-15 NZ NZ532284A patent/NZ532284A/en unknown
- 2002-10-15 AU AU2002341289A patent/AU2002341289B2/en not_active Expired - Fee Related
- 2002-10-15 RS YUP-324/04A patent/RS32404A/en unknown
- 2002-10-15 RS YU32304A patent/RS32304A/en unknown
- 2002-10-15 MX MXPA04003629A patent/MXPA04003629A/en active IP Right Grant
-
2004
- 2004-04-16 CO CO04035089A patent/CO5580781A2/en not_active Application Discontinuation
- 2004-04-16 CO CO04035096A patent/CO5580819A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04003629A (en) | 2004-07-30 |
UA78522C2 (en) | 2007-04-10 |
CO5580819A2 (en) | 2005-11-30 |
RU2004111792A (en) | 2005-05-27 |
RU2004111786A (en) | 2005-10-20 |
MXPA04003628A (en) | 2004-07-30 |
KR20040048960A (en) | 2004-06-10 |
AU2002341289B2 (en) | 2008-07-24 |
CN1982299A (en) | 2007-06-20 |
RS32304A (en) | 2006-12-15 |
NZ532284A (en) | 2006-02-24 |
KR20040052242A (en) | 2004-06-22 |
RS32404A (en) | 2007-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69428476D1 (en) | Heterocyclic compounds as bradykinin antagonists | |
AR052559A1 (en) | PIRAZOL DERIVATIVES TO INHIBIT CDK'S AND GSK'S | |
AR015470A1 (en) | BETA-ARILO-ALFA-ALQUILCARBOXILICO ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURES FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN, INTERMEDIARY COMPOUNDS AND PROCEDURE FOR PREPARATION | |
PE20040373A1 (en) | HERBICIDAL COMPOSITIONS INCLUDING ISOXAZOLINE DERIVATIVES | |
AR025975A1 (en) | CHEMICAL COMPOUNDS. | |
ATE496035T1 (en) | NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS | |
MY119238A (en) | 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
ES2258459T3 (en) | PINROLOTRIAZINAS INHIBIDORAS DE QUINASAS. | |
CO4960658A1 (en) | DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS | |
ATE342256T1 (en) | CHINAZOLINE DERIVATIVES AS MEDICATIONS | |
AR049331A1 (en) | DERIVATIVES OF IMIDAZOPIRIDINES, IMIDAZOQUINOLINAS AND IIMIDAZONAFTIRIDINAS REPLACED WITH AMIDAS AS MODULATORS OF BIOSYNTHESIS OF CYTOKINES. PHARMACEUTICAL COMPOSITIONS. | |
CR7727A (en) | CHEMICAL COMPOUNDS | |
CO5690577A2 (en) | IMIDAZOQUINOLINE DERIVATIVES AS ADENOSINE A3 RECEIVING LIGANDS | |
NZ515284A (en) | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents | |
AR043195A1 (en) | NON-NUCLEOSID INHIBITORS OF THE INVERSE TRANSCRIPT DERIVED FROM PIRAZOL | |
CO6180439A2 (en) | DERIVATIVES OF QUINUCLIDINOL AS ANTAGONISTS OF MUSCARINIC RECEPTORS | |
ATE168102T1 (en) | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK MODULATORS | |
DK1336407T3 (en) | Composition containing an angiotensin II receptor antagonist and a diuretic and its use in the treatment of hypertension | |
CO4700452A1 (en) | DERIVATIVES OF INDOL | |
DE59814334D1 (en) | 5-membered ring heterocycles, their preparation, their use as inhibitors of leukocyte adhesion and pharmaceutical compositions containing them | |
FI873726A (en) | DIHYDROPYRIDINFOERENINGAR, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING. | |
CO5580781A2 (en) | BENZOXAZINE AND BENZOTIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DK50089D0 (en) | 2-OE (4-PIPERIDINYL) METHYLAA-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES, PROCEDURE FOR PREPARING SUCH COMPOUNDS, AND MEDICINAL CONTAINING THESE | |
AR015469A1 (en) | BETA-ARIL-ALFA-OXISUBSTITUTED RENT-CARBOXILIC ACID, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, INTERMEDIARY COMPOUNDS AND PROCEDURE FOR THE PREPARATION | |
ES2183434T3 (en) | CHROMAN DERIVATIVES REPLACED WITH USEFUL CARBOXYL AS ADRENORECEPTORS AGONISTS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |